(E)-3-(benzo[d]thiazol-2-yl)-4-(4-(carboxymethoxy)phenyl)but-3-enoic acid

ID: ALA4877073

PubChem CID: 7921929

Max Phase: Preclinical

Molecular Formula: C19H15NO5S

Molecular Weight: 369.40

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)COc1ccc(/C=C(\CC(=O)O)c2nc3ccccc3s2)cc1

Standard InChI:  InChI=1S/C19H15NO5S/c21-17(22)10-13(19-20-15-3-1-2-4-16(15)26-19)9-12-5-7-14(8-6-12)25-11-18(23)24/h1-9H,10-11H2,(H,21,22)(H,23,24)/b13-9+

Standard InChI Key:  LYQVLDZELZRNHN-UKTHLTGXSA-N

Molfile:  

 
     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
   37.7503   -3.3760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7492   -4.1956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.4572   -4.6045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.4555   -2.9672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.1641   -3.3724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.1643   -4.1911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.9430   -4.4438    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   40.4240   -3.7813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.9426   -3.1193    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.2412   -3.7810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6501   -4.4886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.2417   -5.1965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4245   -5.1968    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   41.6506   -5.9040    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   41.6495   -3.0732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.4667   -3.0729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.8712   -3.7817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.6876   -3.7817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.0968   -3.0733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.6835   -2.3634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.8684   -2.3669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.9139   -3.0719    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   45.3237   -3.7790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.9163   -4.4873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.3261   -5.1944    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   44.0992   -4.4887    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 10 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 19 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
M  END

Associated Targets(Human)

GLO1 Tchem Glyoxalase I (402 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 369.40Molecular Weight (Monoisotopic): 369.0671AlogP: 3.78#Rotatable Bonds: 7
Polar Surface Area: 96.72Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.29CX Basic pKa: 1.93CX LogP: 3.33CX LogD: -2.75
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.66Np Likeness Score: -1.03

References

1. Azuma M, Inoue M, Nishida A, Akahane H, Kitajima M, Natani S, Chimori R, Yoshimori A, Mano Y, Uchiro H, Tanuma SI, Takasawa R..  (2021)  Addition of hydrophobic side chains improve the apoptosis inducibility of the human glyoxalase I inhibitor, TLSC702.,  40  [PMID:33711442] [10.1016/j.bmcl.2021.127918]

Source